CapsPlus
CapsPlus, licence 80041841: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Capsules Plus
- Licence holder
- Promedics Nutraceutical Ltd.
- NPN or DIN-HM
- 80041841
- Status
- Active licence
- Licence date
- 22 April 2013
- Revision date
- 5 February 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Echinacea angustifolia Source : Racine et rhizome | 200.0 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Extrait de graine de Pamplemousse, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 14.0 Année(s) | minimum: 3.0 Capsule ; maximum: 3.0 Capsule | minimum: 2.0 Jour(s) ; maximum: 2.0 Jour(s) |
Uses authorised in Canada
Traditionally used in Herbal Medicine to help relieve the symptoms of upper respiratory tract infections. Traditionally used in Herbal Medicine to help relieve sore throats.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking immunosuppressants. Consult a health care practitioner prior to use if you have an autoimmune disorder, or if you have a progressive systemic disease such as tuberculosis, leukosis, collagenosis, multiple sclerosis, AIDS and/or HIV infection.
Source
Official Health Canada record, licence 80041841
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.